LRA Joins NIAMS Coalition in Supporting Congressional Act Promoting Clinical Trial Diversity
The Lupus Research Alliance and Lupus Therapeutics support diversity in clinical trials to ensure that populations that test potential treatments reflect the population with the disease. LRA joined 42 other members of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Coalition in sending a letter to Congresswoman Robin L. Kelly in support […] Read More